Form 4 holding
Chief Accounting Officer
C4 Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 71,916
- Estimated value
- $135,921
- Report date
- 14 Feb 2026
- Price
- $1.89
- Ownership
- Direct
Mark Mossler - Chief Accounting Officer at C4 Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Accounting Officer
- Issuer ticker
- CCCC on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Mark Mossler since 20 Aug 2025
Reported holdings for Mark Mossler in C4 Therapeutics, Inc.
Transaction history for Mark Mossler in C4 Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.